Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christoph Dierig"'
Autor:
Ed Waddingham, Silvia Kuhls, Richard Nixon, Gemma Hodgson, Christoph Dierig, Shahrul Mt-Isa, Thai-Son Tong, Andrew Thomson, John Stuart Pears, Isabelle Stöckert, Kimberley Hockley
Publikováno v:
Biometrical Journal. 58:8-27
While benefit-risk assessment is a key component of the drug development and maintenance process, it is often described in a narrative. In contrast, structured benefit-risk assessment builds on established ideas from decision analysis and comprises a
Autor:
Richard, Nixon, Christoph, Dierig, Shahrul, Mt-Isa, Isabelle, Stöckert, Thaison, Tong, Silvia, Kuhls, Gemma, Hodgson, John, Pears, Ed, Waddingham, Kimberley, Hockley, Andrew, Thomson
Publikováno v:
Biometrical journal. Biometrische Zeitschrift. 58(1)
While benefit-risk assessment is a key component of the drug development and maintenance process, it is often described in a narrative. In contrast, structured benefit-risk assessment builds on established ideas from decision analysis and comprises a
Autor:
Bengt I. Eriksson, Frank Misselwitz, Menno V. Huisman, Eva Muehlhofer, Sylvia Haas, Ola E. Dahl, Christoph Dierig, Peter Kälebo, Lars C. Borris, Ajay K. Kakkar
Publikováno v:
Circulation. 114(22)
Background— Rivaroxaban (BAY 59-7939)—an oral, direct Factor Xa inhibitor—could be an alternative to heparins and warfarin for the prevention and treatment of thromboembolic disorders. Methods and Results— This randomized, double-blind, doubl
Publikováno v:
Quantitative Structure-Activity Relationships. 5:50-54
42 1,4-naphthoquinones with substituents in the 2- and 3-position were examined for their inhibitory activity on photosynthetic electron transport through photosystem II. The best ones were active in concentrations in the μM range or less. A QSAR wa